Clinical Trial Update: Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for bempegaldesleukin and pembrolizumab, with or without chemotherapy, in locally advanced or metastatic solid tumors; terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bempegaldesleukin (bempegaldesleukin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Nektar Therapeutics | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-03-09